New Zealand’s Psilocybin Prescription Policy: A Cautious Step Towards Novel Depression Treatment
New Zealand’s Psilocybin Prescription Policy: A Cautious Step Towards Novel Depression Treatment New Zealand has taken a significant, albeit cautious, step towards exploring the therapeutic potential of psilocybin, a psychedelic compound found in certain mushroom species, for the treatment of depression. Deputy Prime Minister David Seymour recently announced a relaxation of regulations, allowing for the prescription of psilocybin under strictly controlled conditions to patients suffering from treatment-resistant depression. While psilocybin remains an unapproved medicine in New Zealand, a highly experienced…